Cargando…
The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
OBJECTIVE: The receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) signaling pathway (RANKL/RANK/OPG signaling) is implicated in the osteolysis associated with diabetic Charcot neuroarthropathy (CN); however, the links with medial arterial calcification (MA...
Autores principales: | Ndip, Agbor, Williams, Alfred, Jude, Edward B., Serracino-Inglott, Ferdinand, Richardson, Steve, Smyth, J.V., Boulton, Andrew J.M., Alexander, M. Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142088/ https://www.ncbi.nlm.nih.gov/pubmed/21659498 http://dx.doi.org/10.2337/db10-1220 |
Ejemplares similares
-
Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development
por: Bruhn-Olszewska, Bożena, et al.
Publicado: (2017) -
Trends in the relation between hyperglycemia correction and active Charcot neuroarthropathy: results from the EPICHAR study
por: Dardari, Dured, et al.
Publicado: (2022) -
RANKL-RANK-OPG Pathway in Charcot Diabetic Foot: Pathophysiology and Clinical-Therapeutic Implications
por: Greco, Tommaso, et al.
Publicado: (2023) -
RANK/RANKL/OPG system in the intervertebral disc
por: Takegami, Norihiko, et al.
Publicado: (2017) -
An overview of Charcot’s neuroarthropathy
por: Dardari, Dured
Publicado: (2020)